Anaemias

Anaemias list

Phosphoglycerate kinase deficiency

General info

Acronym:
PGK
ORPHANET code:
713
OMIM code:
300653
ICD-10 code:
D55.2
Group:
Red cell enzymopathies

PGK is a key enzyme of the glycolytic pathway, involved in the production of ATP (energy). The PGK gene coding for this enzyme is located on the X-chromosome. PGK deficiency is a cause of chronic haemolytic anaemia and myoglobinuria

  • What causes the disease and how common is it?

    This deficiency is very rare, and only 26 unrelated families have been reported so far.

    Since the PGK is a X-chromosome-linked mutation, hemizygous males and homozygous or compound heterozygotes females have reduced enzyme activity. Heterozygous females show variable enzyme expression depending on the pattern of X-chromosomes inactivation (lyonization).

  • What are the most frequent symptoms if I have the disease?

    PGK deficiency is characterized by chronic haemolytic anaemia (often fully compensated), central nervous system dysfunction (neurological disorder), and myopathy (muscle weakness and pain) with recurrent myoglobinuria (dark urine).

  • Which treatment must I follow if I have the disease?

    In cases of severe chronic anaemia, regular blood transfusions are required. Spleen removal (splenectomy) may improve the clinical status in these cases.

  • What is the risk of passing the condition on to my children?

    Since this is a genetic disease linked to X chromosome, there are different parental combinations that may lead to an affected child, as following:

    Parents Children
    Mother: Healthy carrier
    Father: Healthy
    Female: 50% Healthy /50% Healthy carrier
    Male: 50% Healthy/ 50% Affected
    Mother: Healthy
    Father: Affected
    Female: 50% Healthy /50% Healthy carrier
    Male: 100% Healthy
    Mother: Healthy carrier
    Father: Affected
    Female: 50% Healthy carrier/50% Affected
    Male: 50% Healthy/ 50% Affected
    Mother: Affected
    Father: Affected
    Female: 100% Affected
    Male: 100% Affected

Copyright © 2002 - 2014 Enerca

Co-funded by the Health Programme of the European Union.